<DOC>
	<DOCNO>NCT01244984</DOCNO>
	<brief_summary>The primary purpose study assess safety tolerability 52-week teatment fluticasone furoate/GW642444 inhalation powder once-daily FF inhalation powder once-daily Japanese adult subject asthma .</brief_summary>
	<brief_title>A Long-term Safety Study Fluticasone Furoate ( FF ) /GW642444 FF Japanese Subjects With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Out patient least 18 year age Both genderds ; female childbearing potential must willing use birth control method A diagnosis asthma least 6 month prior Screening A best FEV1 least 50 % predict nomal value Screening Subjects receive maintanance therapy asthma , least 4 week prior Screening History lifethreating asthma Respiratory infection oral candidiasis Asthma exacerbation within 12 week Concurrent respiratory disease disease would confound study participation affect subject safety Allergies study drug , study drugs7 excipients , medication relate study drug Taking another investigational medication medication prohibit use study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>asthma</keyword>
	<keyword>Fluticasone furoate</keyword>
	<keyword>GW642444</keyword>
</DOC>